ZTS Class A Zoetis Inc. Class A Common Stock
NYSE · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$69.69
· of 52w range
· above low
· to high
$68.7852w low
$148.7952w high
Market Cap (MRQ)
$28.86B
P/E (TTM)
11.5
EPS (TTM)
$6.07
Revenue (TTM)
$9.52B
your badges
52W Range
$69–$149
Analyst Rating
HOLD
Price Target
$96
P/E
11.5
ROE
64.4%
Net Profit Margin
27.5%
Your badge strip is empty — pin a metric anywhere on this page.
ZTS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$69.69
Market Cap (MRQ)
$28.86B
P/E (TTM)
11.5
EPS (TTM)
$6.07
Revenue (TTM)
$9.52B
ROE (TTM)
64.4%
Debt/Equity (MRQ)
2.9
52W Range
$69–$149
ZTS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Zoetis Inc. Class A Common Stock Company overview from Wikipedia
Zoetis Inc. (/zō-EH-tis/), headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses.
The firm is named Zoetis in allusion to the Greek-derived zoological term zoetic, meaning "pertaining to life". The company was owned by Pfizer until 2013.
History
1950s to 2000s
In the 1950s, Pfizer began research on several drugs, including oxytetracycline, which was found to be effective in livestock.
In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.
In 1988, the division was renamed Pfizer Animal Health.
In 1995, Pfizer acquired Norden Laboratories from GlaxoSmithKline for $1.45 billion, expanding its animal health division into small animal care, including pets.
Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.
In April 2003, Pfizer acquired Pharmacia Corporation for $60 billion in stock. Pfizer absorbed its animal health assets, which included the legacy operations of The Upjohn Company, into Pfizer Animal Health.
In December 2006, Pfizer Animal Health acquired Embrex, which provides inoculations for poultry against various diseases, for $155 million.
In March 2008, Pfizer Animal Health acquired Catapult Genetics, a developer of livestock DNA tests and gene markers, and Bovigen, which markets DNA technology.
In April 2008, Pfizer Animal Health acquired vaccine products from Schering-Plough.
In June 2009, Pfizer Animal Health acquired Vetnex Animal Health from ICICI Bank.
In October 2009, Pfizer acquired Wyeth, including its subsidiary Fort Dodge Animal Health, which was added to Pfizer Animal Health. Some assets were sold to Boehringer Ingelheim to gain regulatory approval for the transaction.
In May 2010, Pfizer Animal Health acquired Microtek, a developer of aquaculture vaccines.
2010s-present
In January 2011, Pfizer Animal Health acquired Synbiotics, a developer of immunodiagnostic tests for companion and food production animals, for $20 million.
In February 2011, Pfizer acquired King Pharmaceuticals; its Alpharma subsidiary was integrated into Pfizer Animal Health.
In June 2012, Pfizer Animal Health was renamed Zoetis.
In February 2013, Zoetis became a public company via an initial public offering, raising $2.2 billion. Most of the money raised through the IPO was used to pay off existing Pfizer debt. In June 2013, Pfizer divested itself of its remaining shares in Zoetis.
In February 2015, the company acquired a portfolio of pet drugs from Abbott Laboratories for approximately $255 million.
In July 2015, the company acquired KL Automation, a robotics company specializing in automation technology for poultry hatchery.
In November 2015, the company announced it would acquire Pharmaq, a developer of aquaculture treatments and diseases, for $765 million.
In August 2016, the company acquired Scandinavian Micro Biodevices for $80 million.
In April 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.
In July 2018, the company acquired Abaxis for $1.9 billion in cash.
In June 2022, Zoetis acquired Basepaws, a privately held genetics company.
In August 2022, the company acquired Newmetrica, a Scottish company that develops digital tools designed to measure health-related quality of life.
In September 2022, Zoetis acquired Jurox, which develops 150 medicines including Alfaxan.
In August 2023, the company opened a 1.4 million square foot facility on 145 acres in Lincoln, Nebraska.
In September 2023, Zoetis acquired Petmedix, a privately held Cambridge, UK-based company, to bring the benefits of species-specific antibody therapies to pet owners.
In December 2023, Zoetis acquired adivo, a German manufacturer of antibodies for pet medicine.
In October 2024, the company sold its medicated feed additive product portfolio and certain water-soluble products to Phibro Animal Health.
In February 2025, the United States Department of Agriculture granted Zoetis conditional approval to deploy its bird flu vaccine in poultry, after a bird flu outbreak had infected nearly 70 people in the USA, resulting in one death, with most cases occurring among farm workers exposed to infected poultry or cattle. In January 2025, the USDA announced plans to replenish its bird flu vaccine stockpile for poultry, aligning with the strain affecting commercial and wild bird populations, similar to efforts following major outbreaks in 2014 and 2015.
In November 2025, the company acquired Veterinary Pathology Group.
In March 2026, the company agreed to acquired the genomics business of Neogen.
In July 2026, the company agreed to acquire VitalRADS, a veterinary teleradiology platform.
Products
Zoetis' manufacturing network, includes 28 sites in 11 countries. Each facility is designed to meet chemical and infectious agent safety regulatory requirements. Many R&D operations are co-located with manufacturing sites, a collaboration that allows bringing new products to market faster.
Zoetis products include:
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealthcare
industryPharmaceuticals
employees14,500
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$9.47B2016-12-31 → 2025-12-31
EPS$6.022016-12-31 → 2025-12-31
Free Cash Flow$2.28B2016-12-31 → 2025-12-31
Net margin27.5%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ZTS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 11.55Y avg ≈35.9 | ≈35.9 | 31.0 | Undervalued | |
| P/S (TTM) | 3.05Y avg ≈9.5 | ≈9.5 | · | · | |
| P/B (MRQ) | 9.25Y avg ≈18.1 | ≈18.1 | · | · | |
| Price / FCF (TTM) | 12.25Y avg ≈45.7 | ≈45.7 | · | · | |
| Price / Cash Flow (TTM) | 10.05Y avg ≈33.9 | ≈33.9 | · | · | |
| EV / Revenue (TTM) | 3.8 | · | · | · | |
| EV / FCF (TTM) | 15.3 | · | · | · | |
| Price / Tangible Book (MRQ) | 12.95Y avg ≈180.4 | ≈180.4 | · | · | |
| PEG Ratio | ≈1.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ZTS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| EBITDA Margin | 5.1%5Y avg ≈5.6% | ≈5.6% | 8.3% | Weak | |
| Pretax Margin (TTM) | 34.4%5Y avg ≈33.7% | ≈33.7% | 15.0% | Top tier | |
| Net Profit Margin (TTM) | 27.5%5Y avg ≈27.0% | ≈27.0% | 10.4% | Top tier | |
| ROA (TTM) | 17.7%5Y avg ≈16.2% | ≈16.2% | 9.8% | Top tier | |
| ROE (TTM) | 64.4%5Y avg ≈52.6% | ≈52.6% | 25.3% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ZTS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 2.95Y avg ≈1.7 | ≈1.7 | 0.9 | High debt | |
| Current Ratio (MRQ) | 3.15Y avg ≈2.9 | ≈2.9 | 1.6 | Strong liquidity | |
| Quick Ratio (MRQ) | 1.65Y avg ≈0.6 | ≈0.6 | 0.8 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 2.95Y avg ≈1.6 | ≈1.6 | 0.9 | High debt |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | ZTS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 2.3%5Y avg ≈7.3% | ≈7.3% | · | · | |
| Revenue CAGR 3Y | 5.4%5Y avg ≈6.7% | ≈6.7% | · | · | |
| Revenue CAGR 5Y | 7.2% | · | · | · | |
| EPS YoY | 10.1%5Y avg ≈12.2% | ≈12.2% | · | · | |
| Net Income YoY | 7.5%5Y avg ≈10.5% | ≈10.5% | · | · | |
| EPS CAGR 3Y | 10.3%5Y avg ≈11.0% | ≈11.0% | · | · | |
| EPS CAGR 5Y | 12.0% | · | · | · | |
| Net Income CAGR 3Y | 8.1%5Y avg ≈9.2% | ≈9.2% | · | · | |
| Net Income CAGR 5Y | 10.3% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | ZTS | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.6 | ≈0.6 | 0.5 | Top tier | |
| Inventory Turnover | 1.15Y avg ≈1.1 | ≈1.1 | 1.5 | Weak | |
| Receivables Turnover | 6.55Y avg ≈6.9 | ≈6.9 | 5.6 | Top tier | |
| Revenue / Employee | ≈$652.9K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$2.12
5Y Div CAGR≈20.1%
Growth Streak≈11
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Jul 20, 2026 | $0.53 | USD | ≈2.7% |
| Apr 20, 2026 | $0.53 | USD | ≈1.7% |
| Jan 20, 2026 | $0.53 | USD | ≈1.6% |
| Oct 31, 2025 | $0.50 | USD | ≈1.4% |
| Jul 18, 2025 | $0.50 | USD | ≈1.3% |
| Apr 21, 2025 | $0.50 | USD | ≈1.3% |
| Jan 21, 2025 | $0.50 | USD | ≈1.1% |
| Oct 31, 2024 | $0.43 | USD | ≈0.97% |
| Jul 18, 2024 | $0.43 | USD | ≈0.93% |
| Apr 18, 2024 | $0.43 | USD | ≈1.1% |
| Jan 18, 2024 | $0.43 | USD | ≈0.82% |
| Oct 31, 2023 | $0.38 | USD | ≈0.96% |
| Jul 20, 2023 | $0.38 | USD | ≈0.84% |
| Apr 20, 2023 | $0.38 | USD | ≈0.80% |
| Jan 19, 2023 | $0.38 | USD | ≈0.83% |
| Oct 31, 2022 | $0.33 | USD | ≈0.86% |
| Jul 20, 2022 | $0.33 | USD | ≈0.70% |
| Apr 20, 2022 | $0.33 | USD | ≈0.61% |
| Jan 19, 2022 | $0.33 | USD | ≈0.54% |
| Oct 28, 2021 | $0.25 | USD | ≈0.47% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
2.5%
Next Report
Nov 05, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 6, 2026 | $1.87 | $1.87 | -0.22% |
| March 31, 2026 | $1.53 | $1.63 | -6.2% | |
| Dec. 31, 2025 | $1.48 | $1.42 | 4.5% | |
| Sept. 30, 2025 | $1.70 | $1.64 | 3.8% | |
| June 30, 2025 | $1.76 | $1.63 | 7.8% | |
| March 31, 2025 | $1.48 | $1.41 | 5.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Cost of Revenue | $2.67B | $2.72B | $2.56B | $2.45B | $2.30B | $2.06B | $1.99B | $1.91B | $1.77B | $1.67B | $1.74B | $1.72B | |
| SG&A Expense | $2.38B | $2.32B | $2.15B | $2.01B | $2.00B | $1.73B | $1.64B | $1.48B | $1.33B | $1.36B | $1.53B | $1.64B | |
| Interest Expense | $222M | $225M | $239M | $221M | $224M | $231M | $223M | $206M | $175M | $166M | $124M | $117M | |
| Other Non-op | $-6M | $-4M | $-2M | $14M | $-4M | $-5M | $0 | $15M | $1M | $2M | $5M | $-3M | |
| Pretax Income | $3.36B | $3.13B | $2.94B | $2.66B | $2.49B | $2.00B | $1.80B | $1.69B | $1.52B | $1.23B | $545M | $820M | |
| Income Tax | $687M | $637M | $596M | $545M | $454M | $360M | $301M | $266M | $663M | $409M | $206M | $233M | |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| EPS (Basic) | $6.03 | $5.47 | $5.08 | $4.51 | $4.29 | $3.44 | $3.14 | $2.96 | $1.76 | $1.66 | $0.68 | $1.16 | |
| EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 | |
| Shares (Basic) | 443,443,000 | 454,200,000 | 461,172,000 | 468,891,000 | 474,348,000 | 475,502,000 | 478,128,000 | 483,063,000 | 489,918,000 | 495,715,000 | 499,707,000 | 501,055,000 | |
| Shares (Diluted) | 443,835,000 | 454,848,000 | 462,269,000 | 470,385,000 | 476,717,000 | 478,569,000 | 481,787,000 | 486,898,000 | 493,161,000 | 498,225,000 | 502,019,000 | 502,025,000 | |
| EBITDA | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.45B | $1.99B | $2.04B | $3.58B | $3.48B | $3.60B | $1.93B | $1.60B | $1.56B | $727M | $1.15B | $882M | |
| Short-term Investments | $0 | · | · | · | · | · | $0 | $99M | $0 | · | · | · | |
| Receivables | $1.41B | $1.32B | $1.30B | $1.22B | $1.13B | $1.01B | $1.09B | $1.04B | $998M | $913M | $937M | $980M | |
| Inventory | $2.46B | $2.31B | $2.56B | $2.35B | $1.92B | $1.63B | $1.41B | $1.39B | $1.43B | $1.50B | $1.47B | $1.29B | |
| Other Current Assets | $450M | $377M | $434M | $365M | $389M | $366M | $318M | $271M | $228M | $248M | $201M | $205M | |
| Current Assets | $6.77B | $5.99B | $6.34B | $7.51B | $6.93B | $6.61B | $4.75B | $4.40B | $4.22B | $3.39B | $3.83B | $3.46B | |
| PP&E (Net) | $3.69B | $3.39B | $3.20B | $2.75B | $2.42B | $2.20B | $1.94B | $1.66B | $1.44B | $1.38B | $1.31B | $1.32B | |
| PP&E (Gross) | $6.61B | $6.03B | $5.80B | $5.05B | $4.49B | $4.15B | $3.68B | $3.26B | $2.91B | $2.74B | $2.52B | $2.46B | |
| Accum. Depreciation | $2.94B | $2.63B | $2.59B | $2.30B | $2.07B | $1.95B | $1.74B | $1.60B | $1.47B | $1.36B | $1.21B | $1.15B | |
| Goodwill | $2.77B | $2.72B | $2.76B | $2.75B | $2.68B | $2.69B | $2.59B | $2.52B | $1.51B | $1.48B | $1.46B | $976M | |
| Intangibles | $998M | $1.13B | $1.34B | $1.38B | $1.47B | $1.71B | $1.89B | $2.05B | $1.27B | $1.23B | $1.19B | $727M | |
| Other Non-current Assets | $327M | $250M | $206M | $147M | $111M | $106M | $98M | $94M | $75M | $73M | $49M | $48M | |
| Total Assets | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Accounts Payable | $445M | $433M | $411M | $405M | $436M | $457M | $301M | $313M | $261M | $265M | $293M | $290M | |
| Accrued Liabilities | $852M | $746M | $683M | $682M | $710M | $556M | $543M | $487M | $432M | $464M | $676M | $475M | |
| Short-term Debt | $0 | $0 | $3M | $2M | $0 | $4M | $0 | $9M | $0 | $0 | $0 | $0 | |
| Current Liabilities | $2.17B | $3.41B | $1.89B | $3.17B | $1.80B | $2.17B | $1.81B | $1.22B | $1.09B | $1.12B | $1.78B | $1.09B | |
| Capital Leases | $197M | $174M | $188M | $186M | $151M | $163M | $164M | $0 | · | · | · | · | |
| Deferred Tax | $137M | $167M | $146M | $142M | $320M | $378M | $434M | $474M | $380M | $244M | $264M | $277M | |
| Other Non-current Liabilities | $250M | $222M | $237M | $217M | $239M | $270M | $229M | $187M | $201M | $248M | $251M | $207M | |
| Total Liabilities | $12.07B | $9.47B | $9.29B | $10.52B | $9.36B | $9.84B | $8.84B | $8.59B | $6.80B | $6.15B | $6.82B | $5.25B | |
| Long-term Debt | $9.04B | $6.57B | $6.56B | $7.90B | $6.59B | $7.20B | $6.45B | $6.44B | $4.95B | $4.47B | $4.86B | $3.62B | |
| Total Debt | $9.04B | $6.57B | $6.57B | $7.90B | $6.59B | $7.20B | $6.45B | $6.45B | $4.95B | $4.47B | $4.86B | · | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.10B | $1.18B | $1.13B | $1.09B | $1.07B | $1.06B | $1.04B | $1.03B | $1.01B | $1.02B | $1.01B | $958M | |
| Retained Earnings | $13.80B | $11.97B | $10.29B | $8.67B | $7.19B | $5.66B | $4.43B | $3.27B | $2.11B | $1.48B | $876M | $709M | |
| Treasury Stock | $10.69B | $7.45B | $5.60B | $4.54B | $2.95B | $2.23B | $2.04B | $1.49B | $852M | $421M | $203M | $0 | |
| AOCI | $-804M | $-940M | $-839M | $-817M | $-764M | $-730M | $-726M | $-629M | $-505M | $-598M | $-622M | $-361M | |
| Stockholders' Equity | $3.42B | $4.77B | $5.00B | $4.41B | $4.54B | $3.77B | $2.71B | $2.19B | $1.79B | $1.50B | $1.07B | $1.31B | |
| Liabilities + Equity | $15.49B | $14.24B | $14.29B | $14.93B | $13.90B | $13.61B | $11.54B | $10.78B | $8.59B | $7.65B | $7.91B | $6.59B | |
| Shares Outstanding | 424,927,535 | 448,473,073 | 458,367,358 | 463,808,059 | 472,574,090 | 475,317,751 | 475,528,210 | 479,562,326 | 486,130,461 | 492,855,297 | 497,400,113 | 501,327,524 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $487M | $497M | $491M | $465M | $448M | $441M | $412M | $308M | $242M | $240M | $199M | $204M | |
| Stock-based Comp | $83M | $74M | $60M | $62M | $58M | $59M | $67M | $53M | $44M | $37M | $43M | $32M | |
| Deferred Tax | $-52M | $-338M | $-61M | $-286M | $-80M | $-62M | $-79M | $-112M | $127M | $-55M | $-85M | $-49M | |
| Amort. of Intangibles | $157M | $170M | $185M | $193M | $204M | $230M | $237M | $157M | $100M | $95M | $64M | $63M | |
| Restructuring | $49M | $43M | $46M | $6M | $33M | $8M | $33M | $26M | $13M | $2M | $301M | $17M | |
| Other Non-cash | $-287M | $234M | $-481M | $-443M | $-250M | $50M | $-105M | $113M | $69M | $-330M | $168M | $-144M | |
| Operating Cash Flow | $2.90B | $2.95B | $2.35B | $1.91B | $2.21B | $2.13B | $1.79B | $1.79B | $1.35B | $713M | $664M | $626M | |
| CapEx | $621M | $655M | $732M | $586M | $477M | $453M | $460M | $338M | $224M | $216M | $224M | $180M | |
| Investing Cash Flow | $-748M | $-315M | $-777M | $-883M | $-458M | $-572M | $-504M | $-2.26B | $-270M | $-214M | $-1.11B | $-187M | |
| Net Debt Issued | $-1.35B | $0 | $-1.35B | $0 | $-600M | $-500M | $0 | $0 | $-750M | $-400M | · | · | |
| Stock Repurchased | $3.23B | $1.86B | $1.09B | $1.59B | $743M | $250M | $626M | $698M | $500M | $300M | $203M | $0 | |
| Net Stock Activity | $-3.23B | $-1.86B | $-1.09B | $-1.59B | $-743M | $-250M | $-626M | $-698M | $-500M | $-300M | $-203M | · | |
| Financing Cash Flow | $-1.87B | $-2.66B | $-3.11B | $-904M | $-1.86B | $123M | $-951M | $533M | $-251M | $-903M | $755M | $-154M | |
| Net Change in Cash | $325M | $-54M | $-1.54B | $96M | $-119M | $1.67B | $332M | $38M | $837M | $-427M | $272M | $272M | |
| Taxes Paid | $715M | $892M | $754M | $638M | $548M | $418M | $418M | $336M | $455M | $408M | $224M | $278M | |
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B | $1.67B | $1.33B | $1.45B | $1.12B | $497M | $440M | $446M | |
| Levered FCF | $2.11B | $2.12B | $1.43B | $1.15B | $1.55B | $1.48B | $1.15B | $1.28B | $1.02B | $386M | $363M | $362M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.2% | 26.9% | 27.4% | 26.2% | 26.2% | 24.5% | 24.0% | 24.5% | 16.3% | 16.8% | 7.1% | 12.2% | |
| Pretax Margin | 35.5% | 33.9% | 34.4% | 32.9% | 32.0% | 29.9% | 28.8% | 29.0% | 28.7% | 25.1% | 11.4% | 17.1% | |
| EBITDA Margin | 5.1% | 5.4% | 5.8% | 5.8% | 5.8% | 6.6% | 6.6% | 5.3% | 4.6% | 4.9% | 4.2% | 4.3% | |
| ROA | 18.0% | 17.4% | 16.1% | 14.7% | 14.8% | 13.0% | 13.4% | 14.7% | 10.6% | 10.5% | 4.7% | · | |
| ROE | 66.0% | 50.9% | 49.9% | 47.2% | 49.0% | 50.6% | 58.6% | 66.4% | 52.9% | 64.3% | 28.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 | 3.0 | 2.6 | 3.6 | 3.9 | 3.0 | 2.2 | · | |
| Quick Ratio | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 | 0.5 | 0.6 | 0.9 | 2.3 | 1.5 | 1.2 | · | |
| Debt / Equity | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 | 1.9 | 2.4 | 3.0 | 2.8 | 3.0 | 4.6 | · | |
| LT Debt / Equity | 2.7 | 1.1 | 1.3 | 1.5 | 1.5 | 1.7 | 2.2 | 2.9 | 2.8 | 3.0 | 4.2 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | · | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.1 | 1.3 | 1.4 | 1.4 | 1.4 | 1.2 | 1.1 | 1.3 | · | |
| Receivables Turnover | 6.5 | 7.1 | 6.8 | 6.9 | 7.2 | 6.4 | 5.9 | 5.7 | 5.6 | 5.3 | 5.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.84 | $10.64 | $10.90 | $9.50 | $9.61 | $7.93 | $5.69 | $4.56 | $3.64 | $3.02 | $2.15 | · | |
| Revenue / Share | $21.33 | $20.35 | $18.48 | $17.18 | $16.31 | $13.95 | $12.99 | $11.96 | $10.76 | $9.81 | $9.49 | $9.53 | |
| Cash Flow / Share | $6.54 | $6.49 | $5.09 | $4.06 | $4.64 | $4.44 | $3.73 | $3.68 | $2.73 | $1.43 | $1.32 | $1.25 | |
| Cash / Share | · | · | · | · | · | · | · | · | $3.22 | $1.48 | $2.32 | · | |
| Dividend Paid / Share | $2.03 | $1.80 | $1.56 | $1.35 | $1.07 | $0.85 | $0.69 | $0.54 | $0.44 | $0.39 | $0.34 | $0.30 | |
| EPS (TTM) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $3.11 | $2.93 | $1.75 | $1.65 | $0.68 | $1.16 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 2.3% | 8.3% | 5.7% | 3.9% | 16.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.4% | 6.0% | 8.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 10.1% | 7.9% | 12.9% | 5.1% | 24.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 10.3% | 8.6% | 14.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 12.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 7.5% | 6.1% | 10.9% | 3.8% | 24.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 8.1% | 6.9% | 12.7% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B | $6.67B | $6.26B | $5.83B | $5.31B | $4.89B | $4.76B | $4.79B | |
| Net Income TTM | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B | $1.64B | $1.50B | $1.43B | $864M | $821M | $339M | $583M | |
| Market Cap | $53.46B | $73.07B | $90.47B | $67.97B | $115.32B | $78.67B | $62.94B | $41.02B | $35.02B | $26.38B | $23.84B | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | $38.41B | $30.12B | $27.54B | · | |
| P/E | 20.9 | 29.8 | 38.9 | 32.6 | 57.1 | 48.4 | 42.6 | 29.2 | 41.2 | 32.4 | 70.5 | 37.1 | |
| P/S | 5.6 | 7.9 | 10.6 | 8.4 | 14.8 | 11.8 | 10.1 | 7.0 | 6.6 | 5.4 | 5.0 | · | |
| P/B | 16.1 | 15.3 | 18.1 | 15.4 | 25.4 | 20.9 | 23.2 | 18.8 | 19.8 | 17.7 | 22.3 | · | |
| P / Tangible Book | · | 79.5 | 100.5 | 243.6 | 298.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | 18.4 | 24.7 | 38.4 | 35.5 | 52.1 | 37.0 | 35.1 | 22.9 | 26.0 | 37.0 | 35.9 | · | |
| P / FCF | 23.4 | 31.8 | 55.8 | 51.3 | 66.4 | 47.0 | 47.1 | 28.3 | 31.2 | 53.1 | 54.2 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 158.7 | 125.5 | 138.4 | · | |
| EV / FCF | · | · | · | · | · | · | · | · | 34.2 | 60.6 | 62.6 | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | 7.2 | 6.2 | 5.8 | · | |
| Earnings Yield | 4.8% | 3.4% | 2.6% | 3.1% | 1.8% | 2.1% | 2.4% | 3.4% | 2.4% | 3.1% | 1.4% | 2.7% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | $2.20B | $2.32B | $2.39B | $2.36B | $2.19B | $2.21B | $2.15B | $2.18B | $2.00B | $2.04B | $2.00B | |
| Cost of Revenue | $673M | $641M | $712M | $683M | $664M | $618M | $707M | $701M | $668M | $643M | $728M | $638M | $607M | $588M | $653M | $607M | |
| SG&A Expense | $592M | $588M | $619M | $579M | $614M | $574M | $625M | $565M | $581M | $547M | $565M | $525M | $556M | $505M | $514M | $501M | |
| Interest Expense | $61M | $62M | $57M | $58M | $53M | $54M | $51M | $57M | $59M | $58M | $59M | $59M | $58M | $63M | $62M | $53M | |
| Other Non-op | $-2M | $-1M | $-8M | $0 | $-1M | $3M | $1M | $-2M | $2M | $-5M | $5M | $-4M | $2M | $-5M | $6M | $1M | |
| Pretax Income | $866M | $758M | $761M | $887M | $912M | $773M | $732M | $874M | $780M | $747M | $650M | $717M | $872M | $697M | $592M | $667M | |
| Income Tax | $175M | $157M | $158M | $166M | $186M | $171M | $151M | $182M | $156M | $148M | $127M | $121M | $202M | $146M | $132M | $139M | |
| Net Income | $691M | $601M | $603M | $721M | $726M | $602M | $581M | $682M | $624M | $599M | $525M | $596M | $671M | $552M | $461M | $529M | |
| EPS (Basic) | $1.65 | $1.42 | $1.38 | $1.63 | $1.63 | $1.34 | $1.28 | $1.51 | $1.37 | $1.31 | $1.15 | $1.29 | $1.45 | $1.19 | $0.99 | $1.13 | |
| EPS (Diluted) | $1.65 | $1.42 | $1.37 | $1.63 | $1.63 | $1.34 | $1.29 | $1.50 | $1.37 | $1.31 | $1.14 | $1.29 | $1.45 | $1.19 | $0.98 | $1.13 | |
| Shares (Basic) | 417,600,000 | 422,100,000 | · | 442,900,000 | 445,100,000 | 447,600,000 | · | 452,900,000 | 455,500,000 | 458,000,000 | · | 460,300,000 | 461,900,000 | 463,500,000 | · | 467,800,000 | |
| Shares (Diluted) | 417,700,000 | 422,400,000 | · | 443,200,000 | 445,500,000 | 448,000,000 | · | 453,500,000 | 456,000,000 | 458,800,000 | · | 461,400,000 | 462,900,000 | 464,600,000 | · | 469,100,000 | |
| EBITDA | $119M | $119M | · | $124M | $123M | $119M | · | $121M | $127M | $126M | · | $124M | $121M | $120M | · | $115M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.48B | $1.94B | · | $2.08B | $1.44B | $1.72B | · | $1.71B | $1.57B | $1.98B | · | $1.75B | $1.72B | $2.11B | · | $2.51B | |
| Short-term Investments | $200M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | $1.57B | $1.51B | $1.59B | $1.54B | $1.54B | $1.36B | $1.32B | $1.41B | $1.38B | $1.29B | · | $1.26B | $1.32B | $1.19B | · | $1.19B | |
| Inventory | $2.57B | $2.55B | $2.43B | $2.46B | $2.44B | $2.37B | $2.31B | $2.42B | $2.45B | $2.65B | · | $2.74B | $2.70B | $2.56B | · | $2.30B | |
| Other Current Assets | $535M | $477M | $436M | $493M | $509M | $430M | $377M | $427M | $467M | $440M | · | $467M | $443M | $411M | · | $552M | |
| Current Assets | $6.36B | $6.47B | $6.77B | $6.58B | $5.92B | $5.88B | $5.99B | $6.28B | $6.20B | $6.36B | · | $6.22B | $6.18B | $6.27B | · | $6.55B | |
| PP&E (Net) | $3.76B | $3.72B | $3.68B | $3.60B | $3.54B | $3.44B | $3.39B | $3.30B | $3.20B | $3.25B | · | $3.09B | $3.01B | $2.91B | · | $2.62B | |
| PP&E (Gross) | · | · | $6.61B | · | · | · | $6.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $3.07B | $3.00B | $2.92B | $2.87B | $2.80B | $2.70B | $2.63B | $2.66B | $2.59B | $2.67B | · | $2.53B | $2.45B | $2.37B | · | $2.23B | |
| Goodwill | $2.77B | $2.78B | $2.77B | $2.76B | $2.76B | $2.72B | $2.72B | $2.74B | $2.74B | $2.76B | $2.76B | $2.76B | $2.71B | $2.74B | $2.75B | $2.69B | |
| Intangibles | $918M | $959M | $998M | $1.04B | $1.07B | $1.08B | $1.13B | $1.19B | $1.23B | $1.29B | · | $1.40B | $1.25B | $1.31B | · | $1.32B | |
| Other Non-current Assets | $384M | $351M | $328M | $293M | $267M | $232M | $250M | $215M | $210M | $227M | · | $216M | $173M | $143M | · | $161M | |
| Total Assets | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Accounts Payable | $452M | $507M | $487M | $410M | $508M | $420M | $433M | $404M | $420M | $405M | · | $388M | $464M | $424M | · | $373M | |
| Accrued Liabilities | · | · | $852M | · | · | · | $746M | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $24M | · | $2M | $2M | $3M | · | $3M | |
| Current Liabilities | $2.06B | $2.05B | $2.23B | $1.81B | $3.37B | $3.38B | $3.41B | $1.70B | $1.80B | $1.91B | · | $1.61B | $1.77B | $1.92B | · | $2.88B | |
| Capital Leases | $190M | $193M | $196M | $204M | $210M | $173M | $174M | $181M | $181M | $184M | · | $191M | $188M | $180M | · | $186M | |
| Deferred Tax | $122M | $130M | $139M | $147M | $156M | $161M | $167M | $172M | $175M | $136M | · | $160M | $121M | $131M | · | $256M | |
| Other Non-current Liabilities | $220M | $219M | $248M | $264M | $274M | $220M | $222M | $220M | $222M | $228M | · | $259M | $217M | $216M | · | $239M | |
| Total Liabilities | $11.93B | $11.92B | $12.14B | $9.76B | $9.50B | $9.44B | $9.47B | $9.12B | $9.21B | $9.30B | · | $9.03B | $9.13B | $9.26B | · | $9.01B | |
| Long-term Debt | · | · | $9.04B | $7.07B | $6.58B | $6.58B | $6.57B | · | · | · | · | $6.55B | $6.55B | $6.56B | · | $6.56B | |
| Total Debt | $9.05B | $9.04B | · | $7.07B | $6.58B | $6.58B | · | $6.57B | $6.56B | $6.59B | · | $6.55B | $6.56B | $6.56B | · | $6.56B | |
| Common Stock | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | · | $5M | $5M | $5M | · | $5M | |
| Paid-in Capital | $1.13B | $1.10B | $1.10B | $1.22B | $1.20B | $1.18B | $1.18B | $1.16B | $1.15B | $1.13B | · | $1.12B | $1.10B | $1.08B | · | $1.07B | |
| Retained Earnings | $14.65B | $14.18B | $13.74B | $13.59B | $12.87B | $12.38B | $11.97B | $11.81B | $11.12B | $10.70B | · | $10.14B | $9.54B | $9.04B | · | $8.53B | |
| Treasury Stock | $11.85B | $11.29B | $10.69B | $8.61B | $8.23B | $7.89B | $7.45B | $6.89B | $6.46B | $5.93B | · | $5.37B | $5.13B | $4.81B | · | $4.14B | |
| AOCI | $-796M | $-772M | $-834M | $-818M | $-877M | $-1.02B | $-940M | $-851M | $-845M | $-841M | · | $-814M | $-895M | $-828M | · | $-809M | |
| Stockholders' Equity | $3.15B | $3.23B | $3.33B | $5.40B | $4.98B | $4.66B | $4.77B | $5.23B | $4.97B | $5.06B | · | $5.08B | $4.62B | $4.49B | · | $4.66B | |
| Liabilities + Equity | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B | $14.35B | · | $14.11B | $13.75B | $13.75B | · | $13.67B | |
| Shares Outstanding | 414,154,046 | 420,348,495 | 424,927,535 | 441,464,339 | 443,945,593 | 446,040,205 | 448,473,073 | 451,549,789 | 453,812,361 | 456,947,205 | · | 459,524,713 | 460,750,652 | 462,495,343 | · | 466,442,095 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $119M | $119M | $121M | $124M | $124M | $119M | $123M | $121M | $127M | $126M | $126M | $124M | $121M | $120M | $119M | $115M | |
| Stock-based Comp | $26M | $25M | $22M | $22M | $22M | $17M | $19M | $18M | $19M | $18M | $17M | $17M | $17M | $9M | $16M | $15M | |
| Deferred Tax | $-33M | $34M | $-48M | $-16M | $-7M | $14M | $-152M | $-42M | $-101M | $-43M | $-21M | $-14M | $-34M | $8M | $-176M | $-34M | |
| Amort. of Intangibles | $38M | $39M | $38M | $39M | $40M | $40M | $42M | $42M | $42M | $44M | $44M | $46M | $48M | $47M | $46M | $48M | |
| Restructuring | $75M | $20M | $16M | $4M | · | · | $-3M | $-2M | $37M | $11M | $8M | $13M | $5M | $20M | $1M | · | |
| Other Non-cash | · | $-378M | · | · | · | $-199M | · | · | · | $-105M | · | · | · | $-140M | · | · | |
| Operating Cash Flow | $655M | $401M | $893M | $938M | $486M | $515M | $905M | $951M | $502M | $595M | $897M | $724M | $183M | $549M | $741M | $526M | |
| CapEx | $117M | $110M | $161M | $133M | $178M | $178M | $216M | $167M | $132M | $140M | $198M | $145M | $166M | $223M | $171M | $154M | |
| Investing Cash Flow | $-300M | $-87M | $-166M | $-160M | $-247M | $-203M | $126M | $-178M | $-132M | $-131M | $-210M | $-271M | $-80M | $-216M | $-438M | $-124M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-1.35B | · | · | |
| Stock Repurchased | $584M | $606M | $2.06B | $394M | $338M | $443M | $553M | $433M | $533M | $339M | $235M | $250M | $324M | $283M | $405M | $377M | |
| Net Stock Activity | · | $-606M | · | · | · | $-443M | · | · | · | $-339M | · | · | · | $-283M | · | · | |
| Financing Cash Flow | $-813M | $-840M | $-495M | $-134M | $-564M | $-677M | $-745M | $-628M | $-763M | $-524M | $-397M | $-416M | $-494M | $-1.80B | $780M | $-529M | |
| Net Change in Cash | $-465M | $-509M | $228M | $649M | $-286M | $-332M | $273M | $140M | $-401M | $-66M | $287M | $37M | $-392M | $-1.47B | $1.07B | $-145M | |
| Taxes Paid | $380M | $50M | $133M | $107M | $428M | $60M | $235M | $176M | $422M | $59M | $168M | $128M | $438M | $20M | $167M | $155M | |
| Free Cash Flow | · | $291M | · | · | · | $438M | · | · | · | $455M | · | · | · | $326M | · | · | |
| Levered FCF | · | $242M | · | · | · | $396M | · | · | · | $408M | · | · | · | $276M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 28.0% | 26.6% | · | 30.0% | 29.2% | 28.4% | · | 28.6% | 26.4% | 27.4% | · | 27.7% | 30.8% | 27.6% | · | 26.4% | |
| Pretax Margin | 35.1% | 33.5% | · | 37.0% | 36.7% | 36.5% | · | 36.6% | 33.0% | 34.1% | · | 33.3% | 40.0% | 34.8% | · | 33.3% | |
| EBITDA Margin | 4.8% | 5.3% | · | 5.2% | 5.0% | 5.4% | · | 5.1% | 5.4% | 5.8% | · | 5.8% | 5.5% | 6.0% | · | 5.7% | |
| ROA | 4.7% | 4.1% | · | 4.9% | 5.0% | 4.4% | · | 4.8% | 4.5% | 4.3% | · | 4.3% | 4.9% | 4.0% | · | 3.9% | |
| ROE | 17.0% | 15.2% | · | 13.6% | 14.4% | 13.0% | · | 13.2% | 13.0% | 12.5% | · | 12.2% | 14.6% | 12.1% | · | 11.3% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | 3.2 | · | 3.6 | 1.8 | 1.7 | · | 3.7 | 3.5 | 3.3 | · | 3.9 | 3.5 | 3.3 | · | 2.3 | |
| Quick Ratio | 1.6 | 1.7 | · | 2.0 | 0.9 | 0.9 | · | 1.8 | 1.6 | 1.7 | · | 1.9 | 1.7 | 1.7 | · | 1.3 | |
| Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.3 | 1.4 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.4 | |
| LT Debt / Equity | 2.9 | 2.8 | · | 1.3 | 1.1 | 1.1 | · | 1.3 | 1.3 | 1.3 | · | 1.3 | 1.4 | 1.5 | · | 1.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.6 | 1.6 | · | 1.6 | 1.7 | 1.7 | · | 1.8 | 1.7 | 1.8 | · | 1.8 | 1.7 | 1.7 | · | 1.7 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.60 | $7.69 | · | $12.23 | $11.21 | $10.44 | · | $11.59 | $10.94 | $11.07 | · | $11.05 | $10.04 | $9.72 | · | $10.00 | |
| Revenue / Share | $5.91 | $5.36 | · | $5.42 | $5.52 | $4.96 | · | $5.27 | $5.18 | $4.77 | · | $4.66 | $4.71 | $4.30 | · | $4.27 | |
| Cash Flow / Share | · | $0.95 | · | · | · | $1.31 | · | · | · | $1.30 | · | · | · | $1.18 | · | · | |
| Cash / Share | $3.56 | $4.62 | · | $4.72 | $3.23 | $3.86 | · | $3.80 | $3.47 | $4.32 | · | $3.82 | $3.73 | $4.56 | · | $5.37 | |
| Dividend / Share | $0.53 | $0.53 | · | $0.00 | $0.50 | $0.50 | · | $0.00 | $0.43 | $0.43 | · | $0.00 | $0.38 | $0.38 | · | $0.00 | |
| EPS (TTM) | $6.07 | $6.05 | · | $5.89 | $5.76 | $5.50 | · | $5.32 | $5.11 | $5.19 | · | $4.91 | $4.75 | $4.42 | · | $4.38 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9.52B | $9.52B | · | $9.39B | $9.38B | $9.26B | · | $9.15B | $8.91B | $8.73B | · | $8.37B | $8.22B | $8.09B | · | $8.01B | |
| Net Income TTM | $2.62B | $2.65B | · | $2.63B | $2.59B | $2.49B | · | $2.43B | $2.34B | $2.39B | · | $2.28B | $2.21B | $2.07B | · | $2.07B | |
| Market Cap | $29.76B | $49.69B | · | $64.60B | $69.23B | $73.44B | · | $88.22B | $78.67B | $77.32B | · | $79.95B | $79.35B | $76.98B | · | $69.17B | |
| Enterprise Value | $37.13B | $56.79B | · | $69.58B | $74.38B | $78.30B | · | $93.08B | $83.66B | $81.93B | · | $84.75B | $84.19B | $81.43B | · | $73.22B | |
| P/E | 11.8 | 19.5 | · | 24.8 | 27.1 | 29.9 | · | 36.7 | 33.9 | 32.6 | · | 35.4 | 36.3 | 37.7 | · | 33.9 | |
| P/S | 3.1 | 5.2 | · | 6.9 | 7.4 | 7.9 | · | 9.6 | 8.8 | 8.9 | · | 9.6 | 9.7 | 9.5 | · | 8.6 | |
| P/B | 9.5 | 15.4 | · | 12.0 | 13.9 | 15.8 | · | 16.9 | 15.8 | 15.3 | · | 15.7 | 17.2 | 17.1 | · | 14.8 | |
| P / Tangible Book | · | · | · | 40.5 | 60.5 | 85.7 | · | 67.7 | 78.6 | 77.0 | · | 87.1 | 120.4 | 174.2 | · | 106.1 | |
| P / Cash Flow | · | 123.9 | · | · | · | 125.1 | · | · | · | 129.9 | · | · | · | 140.2 | · | · | |
| EV / Revenue | 3.9 | 6.0 | · | 7.4 | 7.9 | 8.5 | · | 10.2 | 9.4 | 9.4 | · | 10.1 | 10.2 | 10.1 | · | 9.1 | |
| Earnings Yield | 8.5% | 5.1% | · | 4.0% | 3.7% | 3.3% | · | 2.7% | 2.9% | 3.1% | · | 2.8% | 2.8% | 2.7% | · | 2.9% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $9.47B | $9.26B | $8.54B | $8.08B | $7.78B |
| Net Income | $2.67B | $2.49B | $2.34B | $2.11B | $2.04B |
| Diluted EPS | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 2.7 | 1.4 | 1.3 | 1.8 | 1.5 |
| Current Ratio | 3.0 | 1.8 | 3.4 | 2.4 | 3.9 |
| Quick Ratio | 0.7 | 0.4 | 0.7 | 0.4 | 0.6 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $2.28B | $2.30B | $1.62B | $1.33B | $1.74B |
Institutional owners (13F) 1,581 filers · $35.8B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
1,581
Value held
$35.8B
New positions
170
Exited positions
318
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 170 (-31 vs prior Q) | 318 (+136 vs prior Q) | 521 (-88 vs prior Q) | 585 (-42 vs prior Q) | -6.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6,011,802,148 | 47,780,974 | 16.82% | Shares |
| BlackRock, Inc. | $2,833,452,809 | 39,430,181 | 7.93% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $1,870,370,930 | 26,027,984 | 5.23% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,714,611,578 | 23,860,445 | 4.80% | Shares |
| STATE STREET CORP | $1,413,322,575 | 19,667,723 | 3.95% | Shares |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $1,142,064,009 | 15,892,903 | 3.19% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $951,789,721 | 13,289,622 | 2.66% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $677,201,094 | 9,423,895 | 1.89% | Shares |
| MORGAN STANLEY | $638,034,469 | 8,878,849 | 1.78% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $519,929,070 | 4,398,351 | 1.45% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $471,698,956 | 6,592,578 | 1.32% | Shares |
| JANUS HENDERSON GROUP PLC | $437,568,419 | 3,701,747 | 1.22% | Shares |
| DEUTSCHE BANK AG\ | $420,505,821 | 5,851,737 | 1.18% | Shares |
| NORTHERN TRUST CORP | $398,264,934 | 5,542,234 | 1.11% | Shares |
| Invesco Ltd. | $396,884,095 | 5,523,018 | 1.11% | Shares |
| FIL Ltd | $386,734,926 | 5,381,783 | 1.08% | Shares |
| NORGES BANK | $337,012,405 | 4,689,847 | 0.94% | Shares |
| VAN ECK ASSOCIATES CORP | $305,558,780 | 4,252,140 | 0.85% | Shares |
| FLOSSBACH VON STORCH SE | $302,600,879 | 4,210,978 | 0.85% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $287,726,761 | 4,003,981 | 0.80% | Shares |
| Amundi | $286,622,090 | 3,988,618 | 0.80% | Shares |
| BANK OF AMERICA CORP /DE/ | $282,045,207 | 3,924,926 | 0.79% | Shares |
| UBS Group AG | $261,803,299 | 3,643,241 | 0.73% | Shares |
| Legal & General Group Plc | $256,352,499 | 3,567,388 | 0.72% | Shares |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $255,637,351 | 3,557,436 | 0.72% | Shares |
| CIBC Private Wealth Group LLC | $246,008,713 | 1,681,306 | 0.69% | Shares |
| Bank of New York Mellon Corp | $238,741,846 | 3,322,319 | 0.67% | Shares |
| GOLDMAN SACHS GROUP INC | $229,937,577 | 3,199,799 | 0.64% | Shares |
| CITADEL ADVISORS LLC | $229,108,579 | 3,188,263 | 0.64% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $225,456,582 | 3,137,442 | 0.63% | Shares |
| JPMORGAN CHASE & CO | $192,268,534 | 2,624,825 | 0.54% | Shares |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $173,617,784 | 2,416,056 | 0.49% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $170,008,975 | 2,365,836 | 0.48% | Shares |
| Ruane, Cunniff & Goldfarb L.P. | $169,108,138 | 2,353,300 | 0.47% | Shares |
| BARCLAYS PLC | $165,474,682 | 2,302,737 | 0.46% | Shares |
| Qube Research & Technologies Ltd | $163,792,869 | 2,279,333 | 0.46% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $156,216,242 | 2,173,278 | 0.44% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $152,540,744 | 2,122,749 | 0.43% | Shares |
| JANE STREET GROUP, LLC | $144,534,676 | 2,011,337 | 0.40% | Shares |
| BRANDES INVESTMENT PARTNERS, LP | $138,737,455 | 1,930,651 | 0.39% | Shares |
| HSBC HOLDINGS PLC | $132,131,854 | 1,839,811 | 0.37% | Shares |
| BLS Capital Fondsmaeglerselskab A/S | $131,538,868 | 1,830,488 | 0.37% | Shares |
| ROYAL BANK OF CANADA | $131,385,000 | 1,828,326 | 0.37% | Shares |
| MILLENNIUM MANAGEMENT LLC | $130,336,722 | 1,813,759 | 0.36% | Shares |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | $130,169,165 | 1,864,087 | 0.36% | Shares |
| WELLS FARGO & COMPANY/MN | $130,014,751 | 1,809,278 | 0.36% | Shares |
| Man Group plc | $129,707,516 | 1,805,003 | 0.36% | Shares |
| Nuveen, LLC | $129,322,602 | 1,799,647 | 0.36% | Shares |
| BANQUE PICTET & CIE SA | $128,888,455 | 1,793,605 | 0.36% | Shares |
| RAYMOND JAMES FINANCIAL INC | $125,134,922 | 1,741,371 | 0.35% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×7 filings | July 8, 2016 | · | Initial filing | · | SEC |
| Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC, Scott D. Ferguson ×2 filings | Feb. 4, 2015 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 52 insiders · 30 officers · 21 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Kristin C Peck | Chief Executive Officer | July 10, 2026 A | 105,068 | 0 | 2 | $-2,540,972 |
| James Saccaro | EVP, CFO & COO | Aug. 31, 2026 A | · | 0 | 0 | $0 |
| Wetteny Joseph | Chief Financial Officer | July 10, 2026 A | 22,113 | 0 | 0 | $0 |
| Paul Herendeen | Exec. V.P. and CFO | July 19, 2016 A | · | 0 | 0 | $0 |
| Julie Fuller | Executive Vice President | Sept. 30, 2026 M | 1,588 | 0 | 0 | $0 |
| Kevin Esch | Executive Vice President | July 10, 2026 A | 578 | 0 | 0 | $0 |
| Keith Sarbaugh | Executive Vice President | July 10, 2026 A | 3,346 | 0 | 0 | $0 |
| Rimma Driscoll | Executive Vice President | July 10, 2026 A | 5,715 | 0 | 0 | $0 |
| Astorga Jeannette Ferran | Executive Vice President | July 10, 2026 A | 1,684 | 0 | 0 | $0 |
| Abhay U Nayak | Executive Vice President | July 10, 2026 A | 1,965 | 0 | 0 | $0 |
| Roxanne Lagano | Executive Vice President | July 10, 2026 A | 15,632 | 0 | 0 | $0 |
| Jamie Brannan | Executive Vice President | Feb. 19, 2026 M | 3,290 | 0 | 0 | $0 |
| Nicholas Ashton | Executive Vice President | Feb. 19, 2026 M | 1,822 | 0 | 0 | $0 |
| Robert J Polzer | Executive Vice President | Oct. 10, 2025 A | 5,120 | 0 | 0 | $0 |
| Soria Ester Banque | Executive Vice President | Oct. 4, 2024 A | 588 | 0 | 0 | $0 |
| Wafaa Mamilli | Executive Vice President | Oct. 4, 2024 A | 6,685 | 0 | 0 | $0 |
| Heidi C. Chen | Executive Vice President | April 5, 2024 A | 31,293 | 0 | 0 | $0 |
| Glenn David | Executive Vice President | Jan. 13, 2023 A | 46,572 | 0 | 0 | $0 |
| Timothy J Bettington | Executive Vice President | Oct. 7, 2022 A | · | 0 | 0 | $0 |
| Roman Trawicki | Executive Vice President | March 16, 2022 M | 8,218 | 0 | 0 | $0 |
| Catherine A. Knupp | Executive Vice President | Nov. 10, 2021 S | 43,642 | 0 | 0 | $0 |
| Sherry N Pudloski | Executive Vice President | Oct. 8, 2021 A | · | 0 | 0 | $0 |
| Robert Edward Kelly | Executive Vice President | May 3, 2021 M | 8,300 | 0 | 0 | $0 |
| James Michael Mcfarland | Executive Vice President | April 9, 2021 A | 2,547 | 0 | 0 | $0 |
| Clinton A. Lewis Jr. | Executive Vice President | Dec. 16, 2019 M | 27,904 | 0 | 0 | $0 |
| Andrew Fenton | Executive Vice President | Dec. 6, 2019 M | 23,073 | 0 | 0 | $0 |
| Alejandro Bernal | Executive Vice President | Feb. 27, 2018 M | 11,417 | 0 | 0 | $0 |
| Sandra J. Beaty | Executive Vice President | April 30, 2015 A | 6,721 | 0 | 0 | $0 |
| Joyce J. Lee | Executive Vice President | April 9, 2015 A | 3,838 | 0 | 0 | $0 |
| Stefan Weiskopf | Executive Vice President | Feb. 27, 2015 A | 3,658 | 0 | 0 | $0 |
| Mark Stetter | Director | Sept. 17, 2026 A | 1,572 | 0 | 0 | $0 |
| Frank A Damelio | Director | Aug. 7, 2026 G | 14,808 | 1 | 0 | $501,344 |
| Michael B Mccallister | Director | June 10, 2026 G | 0 | 1 | 0 | $233,280 |
| Louise M Parent | Director | May 20, 2026 M | 28,394 | 0 | 0 | $0 |
| Paul Bisaro | Director | May 13, 2026 P | 27,862 | 1 | 0 | $151,760 |
| Gregory Norden | Director | March 9, 2026 G | 0 | 0 | 0 | $0 |
| Vanessa Broadhurst | Director | Feb. 19, 2026 M | 3,920 | 0 | 0 | $0 |
| Antoinette Renee Leatherberry | Director | Feb. 19, 2026 M | 5,280 | 0 | 0 | $0 |
| Willie M Reed | Director | Feb. 19, 2026 M | 12,864 | 0 | 0 | $0 |
| Gavin Hattersley | Director | Feb. 19, 2026 M | 3,354 | 0 | 0 | $0 |
| Khosla Sanjay | Director | Feb. 19, 2026 A | 1,892 | 0 | 0 | $0 |
| Stephanie Tilenius | Director | Feb. 18, 2026 A | · | 0 | 0 | $0 |
| Robert W Scully | Director | May 21, 2025 M | 21,489 | 0 | 0 | $0 |
| Linda Rhodes | Director | May 21, 2024 M | 11,192 | 0 | 0 | $0 |
| Juan Ramon Alaix | Director | May 20, 2021 D | 215,129 | 0 | 0 | $0 |
| William C Steere JR | Director | May 20, 2021 M | 35,074 | 0 | 0 | $0 |
| Charles H Hill | Director | Feb. 6, 2013 P | 5,000 | 0 | 0 | $0 |
| Amy Schulman | Director | Feb. 6, 2013 P | 5,000 | 0 | 0 | $0 |
| Douglas E. Giordano | Director | Feb. 6, 2013 P | 5,000 | 0 | 0 | $0 |
| Geno J Germano | Director | Feb. 6, 2013 P | 5,000 | 0 | 0 | $0 |
| Pfizer Inc. | 10% owner | June 24, 2013 C | 0 | 0 | 0 | $0 |
| Richard A. Passov | · | July 15, 2014 A | 3,706 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 154 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IHE · iShares Trust | 3.78% | 840,871 SH | Sept. 11, 2026 | Daily |
| SMRI · EA Series Trust | 1.83% | 152,486 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.82% | 246,575 NS | July 31, 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.56% | 37,663 SH | Oct. 1, 2026 | Daily |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.56% | 194,540 SH | Oct. 1, 2026 | Daily |
| CVAR · ETF Opportunities Trust | 1.40% | 7,761 NS | July 31, 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.08% | 2,889 NS | July 31, 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0.93% | 221,136 SH | Oct. 1, 2026 | Daily |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.74% | 17,243 NS | July 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.71% | 1,867,940 SH | Sept. 11, 2026 | Daily |
| COWZ · Pacer Funds Trust | 0.62% | 1,502,929 NS | July 31, 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0.59% | 2,890,747 SH | Aug. 19, 2026 | Daily |
| FLAG · Global X Funds | 0.56% | 123 NS | July 31, 2026 | N-PORT |
| ESLV · Strategy Shares | 0.52% | 951 NS | July 31, 2026 | N-PORT |
| PABU · iShares Trust | 0.51% | 174,679 SH | Sept. 11, 2026 | Daily |
| IYH · iShares Trust | 0.49% | 246,300 SH | Sept. 11, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.47% | 200,057 NS | July 31, 2026 | N-PORT |
| RCGE · EA Series Trust | 0.47% | 6,141 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.45% | 1,264,118 SH | Aug. 19, 2026 | Daily |
| IXJ · iShares Trust | 0.39% | 219,915 SH | Sept. 10, 2026 | Daily |
| CURE · Direxion Shares ETF Trust | 0.37% | 8,250 NS | July 31, 2026 | N-PORT |
| NULC · Nushares ETF Trust | 0.35% | 3,218 NS | July 31, 2026 | N-PORT |
| ESUM · Strategy Shares | 0.33% | 7,829 NS | July 31, 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0.31% | 57,270 NS | July 31, 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.31% | 10,926,000 | Oct. 1, 2026 | Daily |
| SUSA · iShares Trust | 0.30% | 164,110 SH | Sept. 11, 2026 | Daily |
| VFVA · VANGUARD WELLINGTON FUND | 0.29% | 33,789 SH | Aug. 19, 2026 | Daily |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.28% | 754,260 SH | Oct. 1, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.28% | 212,600 NS | July 31, 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.26% | 8,177,172 SH | Aug. 19, 2026 | Daily |
| EVUS · iShares Trust | 0.25% | 13,282 SH | Sept. 11, 2026 | Daily |
| IMCV · iShares Trust | 0.25% | 39,931 SH | Sept. 11, 2026 | Daily |
| DUHP · Dimensional ETF Trust | 0.24% | 375,907 NS | July 31, 2026 | N-PORT |
| QDF · FlexShares Trust | 0.23% | 67,413 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.23% | 1,725,551 SH | Sept. 11, 2026 | Daily |
| IMCB · iShares Trust | 0.21% | 49,261 SH | Sept. 11, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.20% | 2,668,324 SH | Oct. 1, 2026 | Daily |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 206,683 NS | July 31, 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.19% | 50,884 SH | Sept. 11, 2026 | Daily |
| LRND · New York Life Investments ETF Trust | 0.18% | 9,465 NS | July 31, 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.18% | 5,589,000 | Oct. 1, 2026 | Daily |
| DGRO · iShares Trust | 0.18% | 1,051,645 SH | Sept. 11, 2026 | Daily |
| IMCG · iShares Trust | 0.18% | 97,153 SH | Sept. 11, 2026 | Daily |
| SIZE · iShares Trust | 0.18% | 10,276 SH | Sept. 11, 2026 | Daily |
| XOEF · iShares Trust | 0.17% | 526 SH | Sept. 11, 2026 | Daily |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.17% | 7,877,000 | Oct. 1, 2026 | Daily |
| LCOW · Pacer Funds Trust | 0.16% | 529 NS | July 31, 2026 | N-PORT |
| CATH · Global X Funds | 0.15% | 25,943 NS | July 31, 2026 | N-PORT |
| ESGU · iShares Trust | 0.15% | 364,501 SH | Sept. 10, 2026 | Daily |
| ESMV · iShares Trust | 0.15% | 158 SH | Sept. 10, 2026 | Daily |
| GSY · Invesco Actively Managed Exchange-T… | 0.15% | 5,769,000 | Oct. 1, 2026 | Daily |
| PALC · Pacer Funds Trust | 0.15% | 3,973 NS | July 31, 2026 | N-PORT |
| QUAL · iShares Trust | 0.14% | 888,569 SH | Sept. 11, 2026 | Daily |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.13% | 175,000 | Oct. 1, 2026 | Daily |
| VIG · VANGUARD SPECIALIZED FUNDS | 0.13% | 2,368,421 SH | Aug. 19, 2026 | Daily |
| VYM · VANGUARD WHITEHALL FUNDS | 0.13% | 1,680,027 SH | Aug. 19, 2026 | Daily |
| NUDV · Nushares ETF Trust | 0.13% | 834 NS | July 31, 2026 | N-PORT |
| USXF · iShares Trust | 0.12% | 24,978 SH | Sept. 11, 2026 | Daily |
| ESG · FlexShares Trust | 0.12% | 2,010 NS | July 31, 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 6,837 NS | July 31, 2026 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0.11% | 11,940 SH | Oct. 1, 2026 | Daily |
| IVE · iShares Trust | 0.10% | 695,597 SH | Sept. 11, 2026 | Daily |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.10% | 14,060 SH | Oct. 1, 2026 | Daily |
| IQSU · New York Life Investments ETF Trust | 0.10% | 4,253 NS | July 31, 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0.10% | 3,598,101 SH | Aug. 19, 2026 | Daily |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.10% | 96,479 SH | Aug. 19, 2026 | Daily |
| CHRI · Global X Funds | 0.10% | 102 NS | July 31, 2026 | N-PORT |
| LGDX · Tidal Trust III | 0.10% | 1,814 NS | July 31, 2026 | N-PORT |
| IUSV · iShares Trust | 0.10% | 368,059 SH | Sept. 11, 2026 | Daily |
| REVS · Columbia ETF Trust I | 0.09% | 3,986 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 10,356 SH | Oct. 1, 2026 | Daily |
| SUSL · iShares Trust | 0.09% | 14,854 SH | Sept. 11, 2026 | Daily |
| DSI · iShares Trust | 0.09% | 64,531 SH | Sept. 11, 2026 | Daily |
| HAPI · Harbor ETF Trust | 0.08% | 5,320 NS | July 31, 2026 | N-PORT |
| AQLT · iShares Trust | 0.08% | 3,693 SH | Sept. 10, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.08% | 55,607 SH | Oct. 1, 2026 | Daily |
| WRND · New York Life Investments ETF Trust | 0.08% | 109 NS | July 31, 2026 | N-PORT |
| MPLY · Strategy Shares | 0.08% | 158 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.08% | 5,377 NS | July 31, 2026 | N-PORT |
| ESGG · FlexShares Trust | 0.07% | 1,064 NS | July 31, 2026 | N-PORT |
| EGLE · Global X Funds | 0.07% | 21 NS | July 31, 2026 | N-PORT |
| IWF · iShares Trust | 0.07% | 1,245,265 SH | Sept. 11, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.07% | 521,663 SH | Aug. 19, 2026 | Daily |
| IWS · iShares Trust | 0.06% | 135,157 SH | Sept. 11, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.06% | 85,655 SH | Oct. 1, 2026 | Daily |
| CRBN · iShares Trust | 0.06% | 9,378 SH | Sept. 10, 2026 | Daily |
| TOPC · iShares Trust | 0.06% | 258 SH | Sept. 11, 2026 | Daily |
| ACVF · ETF Opportunities Trust | 0.06% | 1,125 NS | July 31, 2026 | N-PORT |
| USCL · iShares Trust | 0.06% | 22,073 SH | Sept. 10, 2026 | Daily |
| HQGO · Lattice Strategies Trust | 0.06% | 354 NS | July 31, 2026 | N-PORT |
| XTR · Global X Funds | 0.05% | 34 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.05% | 452 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.05% | 344 NS | July 31, 2026 | N-PORT |
| XVV · iShares Trust | 0.05% | 4,833 SH | Sept. 10, 2026 | Daily |
| XCLR · Global X Funds | 0.05% | 24 NS | July 31, 2026 | N-PORT |
| ILCV · iShares Trust | 0.05% | 9,460 SH | Sept. 11, 2026 | Daily |
| PTLC · Pacer Funds Trust | 0.05% | 21,352 NS | July 31, 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.05% | 57,993 NS | July 31, 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0.05% | 7,112 NS | July 31, 2026 | N-PORT |
| XYLD · Global X Funds | 0.05% | 21,020 NS | July 31, 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0.05% | 10,888,932 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.05% | 95,134 SH | Aug. 19, 2026 | Daily |
| TOV · EA Series Trust | 0.05% | 1,758 NS | July 31, 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.05% | 34,718 NS | July 31, 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0.05% | 36 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.05% | 64,727 SH | Oct. 1, 2026 | Daily |
| IVV · iShares Trust | 0.05% | 5,283,923 SH | Sept. 11, 2026 | Daily |
| ILCB · iShares Trust | 0.05% | 8,221 SH | Sept. 9, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.05% | 1,582 NS | July 31, 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0.05% | 10,102 NS | July 31, 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.04% | 72,430 SH | Oct. 1, 2026 | Daily |
| PBP · Invesco Exchange-Traded Fund Trust | 0.04% | 2,457 SH | Oct. 1, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.04% | 70,832 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.04% | 18,056 SH | Sept. 10, 2026 | Daily |
| IWB · iShares Trust | 0.04% | 290,521 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.04% | 115,640 SH | Sept. 10, 2026 | Daily |
| ITOT · iShares Trust | 0.04% | 544,118 SH | Sept. 11, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.04% | 9,771 SH | Oct. 1, 2026 | Daily |
| ILCG · iShares Trust | 0.04% | 17,162 SH | Sept. 11, 2026 | Daily |
| VV · VANGUARD INDEX FUNDS | 0.04% | 440,643 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.04% | 11,984,400 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.04% | 69,366 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.04% | 35,465 SH | Aug. 19, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.04% | 2,917 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.04% | 17,007 NS | July 31, 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.04% | 32,772 NS | July 31, 2026 | N-PORT |
| TOK · iShares Trust | 0.04% | 1,209 SH | Sept. 11, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.04% | 325 SH | Oct. 1, 2026 | Daily |
| URTH · iShares, Inc. | 0.03% | 37,976 SH | Sept. 10, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.03% | 9,950 NS | July 31, 2026 | N-PORT |
| ACWI · iShares Trust | 0.03% | 138,514 SH | Sept. 9, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.03% | 356,907 SH | Aug. 19, 2026 | Daily |
| TILT · FlexShares Trust | 0.03% | 8,216 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.03% | 69,465 NS | July 31, 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.02% | 2,228 NS | July 31, 2026 | N-PORT |
| NULV · Nushares ETF Trust | 0.02% | 5,737 NS | July 31, 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 54,015 SH | Aug. 19, 2026 | Daily |
| IWD · iShares Trust | 0.02% | 198,738 SH | Sept. 11, 2026 | Daily |
| QDEF · FlexShares Trust | 0.02% | 1,148 NS | July 31, 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0.00% | 3,000 | Sept. 30, 2026 | Daily |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 66,000 | Oct. 1, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 6,792 NS | July 31, 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| BND · VANGUARD BOND INDEX FUNDS | · | · | July 15, 2026 | Daily |
| VCRB · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| VPLS · VANGUARD MALVERN FUNDS | · | · | July 15, 2026 | Daily |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | July 15, 2026 | Daily |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | July 30, 2026 | Daily |
| VCEB · VANGUARD WORLD FUND | · | · | July 30, 2026 | Daily |
ZTS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 24 analysts
BUY
Median target
$89.50
+28.4%
4 16.7%
Strong Buy
8 33.3%
Buy
12 50.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
14 analysts · 2026-09-28Mean target $96.00 +37.8%
← Below all targets
Current price $69.69
Low$80.00
Mean$96.00
High$155.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | · |
| JNJ | · | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | · | 14.5 | 1.3% | 28.1% | 36.9% | · |
| PFE | · | 18.3 | -1.7% | 12.4% | 8.9% | · |
| BMY | · | 15.6 | -0.22% | 14.6% | 40.5% | · |
| RPRX | · | 21.7 | 5.1% | 32.4% | 8.0% | · |
| VTRS | · | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | · |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026